Back
  1. Home
  2. Profile of Paolo D'arrigo (ULiège)
Profil

D'arrigo Paolo

See author's contact details
Main Referenced Co-authors
Romano, Simona (16)
Romano, Maria Fiammetta (15)
Tufano, Martina (11)
Rea, Anna (8)
Rogister, Bernard  (7)
Main Referenced Keywords
Humans (5); PD-L1 (3); Aged (2); B7-H1 Antigen/metabolism (2); Cell Line, Tumor (2);
Main Referenced Unit & Research Centers
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège (1)
Main Referenced Disciplines
Oncology (15)
Biochemistry, biophysics & molecular biology (9)
Immunology & infectious disease (4)
Cardiovascular & respiratory systems (1)
Human health sciences: Multidisciplinary, general & others (1)

Publications (total 23)

The most downloaded
551 downloads
Romano, S., Tufano, M., D'arrigo, P., Vigorito, V., Russo, S., & Romano, M. F. (2020). Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis. Seminars in Cancer Biology, 60, 181-190. doi:10.1016/j.semcancer.2019.08.015 https://hdl.handle.net/2268/248236

The most cited

84 citations (OpenAlex)

D'arrigo, P., Russo, M., Rea, A., Tufano, M., Guadagno, E., Del Basso De Caro, M. L., Pacelli, R., Hausch, F., Staibano, S., Ilardi, G., Parisi, S., Romano, M. F., & Romano, S. (2017). A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma. Oncotarget, 8 (40), 68291-68304. doi:10.18632/oncotarget.19309 https://hdl.handle.net/2268/248245

Dubois, M., D'arrigo, P., Sanchez Gil, J., Lassence, C., Neirinckx, V., Lombard, A., & Sadzot, C. (27 October 2024). Oncolytic Herpes Simplex Virus type 1 armed with CXCL12-antagonist “P2G” to disrupt CXCR4 pathway in Glioblastoma [Poster presentation]. 16th international oncolytic virus conference, Rotterdam, Netherlands.

Sanchez Gil, J., Dubois, M., Neirinckx, V., LOMBARD, A., Coppieters't Wallant, N., D'arrigo, P., Isci, D., Aldenhoff, T., Brouwers, B., Lassence, C., ROGISTER, B., Lebrun, M., & Sadzot, C. (2022). Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: a proof-of-principle. Molecular Therapy: Oncolytics. doi:10.1016/j.omto.2022.06.002
Peer Reviewed verified by ORBi

D'arrigo, P., Sanchez Gil, J., Dubois, M., Lebrun, M., ROGISTER, B., & Sadzot, C. (02 August 2021). An armed oncolytic herpesvirus to counteract gioblastoma stem-like cells functions [Poster presentation]. International Herpesvirus Workshop.
Peer reviewed

D'arrigo, P., Sanchez Gil, J., Lebrun, M., Rogister, B., & Sadzot, C. (01 April 2021). An oncolytic herpesvirus to counteract Glioblastoma Stem Cells function [Paper presentation]. Journée des chercheurs Télévie, Belgium.

Sanchez Gil, J., D'arrigo, P., Neirinckx, V., Isci, D., Brouwers, B., LOMBARD, A., Rogister, B., Lebrun, M., & Sadzot, C. (2021). Targeting of CXCR4+ Glioblastoma initiating cells with a retargeted Oncolytic Herpesvirus (oHSV): proof of concept [Paper presentation]. IHW2021: 45th International Herpesvirus Workshop.

Tufano, M., D'arrigo, P., D'Agostino, M., Giordano, C., Marrone, L., Cesaro, E., Romano, M. F., & Romano, S. (2021). PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma Cells. Cells, 10 (9), 2366. doi:10.3390/cells10092366
Peer Reviewed verified by ORBi

Sanchez Gil, J., D'arrigo, P., Lebrun, M., Isci, D., Coppieters, N., Rogister, B., Chevigné, A., & Sadzot, C. (2021). Targeting of CXCR4+ Glioblastoma initiating cells with a retargeted oncolytic herpesvirus [Poster presentation]. Journée des chercheurs Télévie.

D'arrigo, P., Sanchez Gil, J., Lebrun, M., ROGISTER, B., & Sadzot, C. (18 December 2020). An oncolytic herpesvirus to counteract Glioblastoma Stem Cells function [Poster presentation]. BELVIR.

Troiani, T., Giunta, E. F., Tufano, M., Vigorito, V., D'arrigo, P., Argenziano, G., Ciardiello, F., Romano, M. F., & Romano, S. (2020). Alternative macrophage polarisation associated with resistance to anti-PD1 blockade is possibly supported by the splkcing of FKBP51 immunophilin in melanoma patients. British Journal of Cancer. doi:10.1038/s41416-020-0840-8
Peer Reviewed verified by ORBi

Romano, S., Tufano, M., D'arrigo, P., Vigorito, V., Russo, S., & Romano, M. F. (2020). Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis. Seminars in Cancer Biology, 60, 181-190. doi:10.1016/j.semcancer.2019.08.015
Peer Reviewed verified by ORBi

Romano, S., D'arrigo, P., Tufano, M., Staibano, S., Rea, A., Merolla, F., Ilardi, G., Petrella, A., & Romano, M. F. (2019). TRAF2 and FKBP51 as possible markers for identification of suitable melanoma tumors for tumor necrosis factor-α inhibition. Melanoma Research, 29 (2), 145-150. doi:10.1097/CMR.0000000000000553
Peer Reviewed verified by ORBi

D'arrigo, P.* , Di Gregorio, M.* , Romano, S., Tufano, M., Rea, A., Hausch, F., Dedobbeleer, M., Vigorito, V., Russo, S., Bauder, M., ROGISTER, B., & Romano, M. F. (2019). The Splicing FK506-binding protein-51 Isoform Plays a Role in Glioblastoma Resistance Through Programmed Cell Death ligand-1 Expression Regulation. Cell Death Discovery, 5 (1), 137. doi:10.1038/s41420-019-0216-0
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Troiani, T., Romano, S., D'arrigo, P., Rea, A., Tufano, M., Giunta, E. F., Matarrese, G., Procaccini, C., Novizio, N., Faicchia, D., Argenziano, G., Ciardiello, F., & Romano, M. F. (2018). Identification of a highly suppressive Treg subset associated with immunotherapy response [Poster presentation]. AACR Annual meeting 2018.

Romano, S., D'arrigo, P., Troiani, T., Rea, A., Tufano, M., Giunta, E. F., Matarrese, G., Procaccini, C., Novizio, N., Vigorito, V., Faicchia, D., Argenziano, G., & Romano, M. F. (2018). Identification of an highly suppressive Treg subset associated to immunotherapy response [Poster presentation]. Keystone Symposia, Cancer immunotherapy: Combinations.

D'arrigo, P., Russo, M., Guadagno, E., Pacelli, R., Del Basso De Caro, M., Rea, A., Tufano, M., Staibano, S., Ilardi, G., Romano, M. F., & Romano, S. (2017). Ionizing radiation-induced PD-L1 upregulation in glioma: a crucial role for the molecular chaperone FKBP5 [Poster presentation]. AACR Annual Meeting 2017.

D'arrigo, P., Russo, M., Rea, A., Tufano, M., Guadagno, E., Del Basso De Caro, M. L., Pacelli, R., Hausch, F., Staibano, S., Ilardi, G., Parisi, S., Romano, M. F., & Romano, S. (2017). A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma. Oncotarget, 8 (40), 68291-68304. doi:10.18632/oncotarget.19309
Peer Reviewed verified by ORBi

Romano, S., Simeone, E., D'Angelillo, A., D'arrigo, P., Russo, M., Capasso, M., Lasorsa, V. A., Zambrano, N., Ascierto, P. A., & Romano, M. F. (2017). FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapy. Cancer Immunology, Immunotherapy, 66 (9), 1143-1151. doi:10.1007/s00262-017-2004-0
Peer Reviewed verified by ORBi

Romano, S., D'arrigo, P., Russo, M., Tufano, M., Rea, A., & Romano, M. F. (2016). FKBP51 plays a role in chromatin remodeling in melanoma by acting as co-chaperone of p300 [Poster presentation]. 58th Annual meeting of the Italian Cancer Society.

Russo, M., D'arrigo, P., Hausch, F., Rea, A., Tufano, M., Romano, M. F., & Romano, S. (2016). Study of PD-L1 regulation and expression in glioblastoma and its role in cancer resistance [Poster presentation]. AACR 107th Annual Meeting 2016.

Romano, S., D'Angelillo, A., Staibano, S., Simeone, E., D'arrigo, P., Ascierto, P. A., Scalvenzi, M., Mascolo, M., Ilardi, G., Merolla, F., Jovarauskaite, E., & Romano, M. F. (2015). Immunomodulatory pathways regulate expression of a spliced FKBP51 isoform in lymphocytes of melanoma patients. Pigment Cell and Melanoma Research, 28 (4), 442-52. doi:10.1111/pcmr.12378
Peer Reviewed verified by ORBi

Romano, S., D'Angelillo, A., D'arrigo, P., Russo, M., & Romano, M. F. (2015). FKBP51 and chromatin remodeling [Poster presentation]. Genomic imprinting in development and disease.

Giordano, A., D'Angelillo, A., Romano, S., D'arrigo, P., Corcione, N., Bisogni, R., Messina, S., Polimeno, M., Pepino, P., Ferraro, P., & Romano, M. F. (2014). Tirofiban induces VEGF production and stimulates migration and proliferation of endothelial cells. Vascular Pharmacology, 61 (2-3), 63-71. doi:10.1016/j.vph.2014.04.002
Peer Reviewed verified by ORBi

Romano, S., D'Angelillo, A., D'arrigo, P., Staibano, S., Greco, A., Brunetti, A., Scalvenzi, M., Bisogni, R., Scala, I., & Romano, M. F. (2014). FKBP51 increases the tumour-promoter potential of TGF-beta. Clinical and Translational Medicine, 3 (1), 1.
Peer Reviewed verified by ORBi

Contact ORBi